Institute of Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115, Bonn, Germany.
Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121, Bonn, Germany.
Nat Commun. 2021 Jan 8;12(1):144. doi: 10.1038/s41467-020-20418-3.
The potent and selective Gq protein inhibitor depsipeptide FR900359 (FR), originally discovered as the product of an uncultivable plant endosymbiont, is synthesized by a complex biosynthetic system comprising two nonribosomal peptide synthetase (NRPS) assembly lines. Here we characterize a cultivable bacterial FR producer, enabling detailed investigations into biosynthesis and attachment of the functionally important FR side chain. We reconstitute side chain assembly by the monomodular NRPS FrsA and the non-heme monooxygenase FrsH, and characterize intermolecular side chain transesterification to the final macrocyclic intermediate FR-Core, mediated by the FrsA thioesterase domain. We harness FrsA substrate promiscuity to generate FR analogs with altered side chains and demonstrate indispensability of the FR side chain for efficient Gq inhibition by comparative bioactivity, toxicity and docking studies. Finally, evolution of FR and side chain biosynthesis is discussed based on bioinformatics analyses. Side chain transesterification boosts potency and target affinity of selective Gq inhibitor natural products.
强效且选择性的 Gq 蛋白抑制剂 FR900359(FR)最初被发现是一种不可培养的植物内共生体的产物,它由包含两条非核糖体肽合成酶(NRPS)装配线的复杂生物合成系统合成。在这里,我们鉴定了一种可培养的 FR 产生菌,使我们能够详细研究其生物合成和功能重要的 FR 侧链的附着。我们通过单结构域 NRPS FrsA 和非血红素单加氧酶 FrsH 重新构建侧链装配,并通过 FrsA 硫酯酶结构域介导的分子间侧链酯交换反应来表征最终的大环中间产物 FR-Core。我们利用 FrsA 底物的多功能性来生成具有改变的侧链的 FR 类似物,并通过比较生物活性、毒性和对接研究证明 FR 侧链对于高效抑制 Gq 的不可或缺性。最后,基于生物信息学分析讨论了 FR 和侧链生物合成的进化。侧链酯交换反应提高了选择性 Gq 抑制剂天然产物的效力和靶标亲和力。